HEPATOCELLULAR CARCINOMA [neop]    
Characterized [acty]    
Curative treatment [fndg]    
Reported [inpr]    
HEPATOCELLULAR CARCINOMA [neop]    
effective [qlco]    
PREVENT [phsu]    
HEPATOCELLULAR CARCINOMA [neop]    
Patients [podg]    
Curative [cnce]    
ABLATION [topp]    
resection [topp]    
HEPATOCELLULAR CARCINOMA [neop]    
Assigned [ftcn]    
Receive [qlco]    
Placebo [topp]    
mg day [qnco]    
>90 [qnco]    
mg day [qnco]    
DOUBLE BLIND [resa]    
HEPATOCELLULAR CARCINOMA [neop]    
Survey [inpr]    
WEEKS [tmco]    
Dynamic [ftcn]    
Computed Tomography [diap]    
Imaging, Magnetic Resonance [diap]    
HEPATOCELLULAR CARCINOMA [neop]    
Specific [qlco]    
Tumor Markers [bacs]    
monitor [hlca]    
4 Weeks [tmco]    
Primary [qlco]    
superiority [socb]    
Active [ftcn]    
Drug [phsu]    
Placebo [topp]    
Concern [idcn]    
Disease-Free Survival [qnco]    
secondary [neop]    
Evaluate [hlca]    
Dose-response relationship [biof]    
occurrence [ftcn]    
DEATH [orgf]    
Treated [ftcn]    
Events [evnt]    
Hazard Ratio [qnco]    
occurrence [ftcn]    
DEATH [orgf]    
Calculated [ftcn]    
Enrollment [hlca]    
Commence [acty]    
March [qlco]    
Disease-Free Survival [qnco]    
Assessed [acty]    
Patients [podg]    
Including [ftcn]    
Placebo [topp]    
Group [idcn]    
mg day [qnco]    
Group [idcn]    
>90 [qnco]    
mg day [qnco]    
Group [idcn]    
occurrence [ftcn]    
DEATH [orgf]    
Diagnosed [fndg]    
Patients [podg]    
Groups [idcn]    
Second [qnco]    
Interim [tmco]    
Indicated [fndg]    
PREVENT [phsu]    
occurrence [ftcn]    
DEATH [orgf]    
One-sided [spco]    
Placebo [topp]    
Combined [qlco]    
Active [ftcn]    
Drug [phsu]    
Groups [idcn]    
Study [mnob]    
Discontinued [fndg]    
March [qlco]    
Efficacy [qlco]    
suppressing [ftcn]    
HEPATOCELLULAR CARCINOMA [neop]    
confirmed [qlco]    
DOUBLE BLIND [resa]    
Randomized [resa]    
Hepatology [bmod]    
